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chest tube was inserted. Chest drainage continued for several 
days, with excessive serous fluid losses and decreased plasma 
protein (4.4 g/dL) and fibrinogen (71.3 mg/dL) levels. 
Fibrinogen (200 mglkg per day for 2 days) was administered 
again, and the fluid leakage stopped completely within 2 days. 
On the basis of a high D-dimer level (736 ng/mL) detected 
after the second fibrinogen administration, we speculated that 
the fibrinolytic system had been greatly amplified in this 
cyanotic patient. Therefore, we started an oral medication of 
tranexamic acid (Transamin-G; Dai-Ichi, Inc, Tokyo, Japan) 
30 mglkg daily as an antifibrinolytic therapy. Additional pro-
phylactic fibrinogen infusion was achieved twice at 2-week 
intervals. Since then, the plasma fibrinogen level has been 
within normal range (no less than 170 mgldL), and the plas-
ma D-dimer level has been maintained at a relatively lower 
level (200 to 600 ng/mL), leaving the patient in stable condi-
tion without any fluid leakage. Neither thrombocytopenia nor 
bleeding tendency was observed. No thrombotic events 
occurred. A bidirectional Glenn shunt was successfully done 
6 months after the B-T shunt. 
LeBlanc and associates2 first described excessive fluid leak-
age after a modified B-T shunt. Bolton and Cannon3 suggest-
ed that rapid wetting of the graft with organic solvents or a 
high blood flow with faulty formation of fibrin may be 
responsible for the leakage. However, the mechanism still 
remains unclear. In most of the cases' previously described, 
conservative management failed and surgical interventions 
were required. Maitland and coworkers4 reported 2 cases in 
which leakage was controlled with intraluminal fibrin glue. 
Noyez and Daenen1 reported the case of a patient treated with 
fibrin glue and collagen fleece wrapping. Intravenous fibrino-
gen administration was first described by Suzuki and associ-
ates5 as an effective conservative management of the leakage. 
Human fibrinogen products were originally developed for 
congenital fibrinogenopenia and are commercially available 
in Germany and Japan. According to their report, 7 patients 
were successfully treated with fibrinogen administration 
(150-200 mglkg per day for 3 or 4 days), and in 2 of those 
cases the plasma fibrinogen level was much lower than the 
normal range at the beginning of the leakage. As we 
described, the fact that plasma fibrinogen level decreased and 
plasma D-dimer level increased at the beginning of the fluid 
losses may be an important clue to the mechanism of leakage. 
We speculate that the fibrinolytic system could be greatly 
amplified in some cyanotic patients with polycythemia 
against great thrombotic tendency owing to high blood vis-
cosity. A probable explanation is that the fibrin cross-linking 
step and newly formed fibrin clots in a PTFE graft wall could 
be easily impaired and degraded when this overwhelming fib-
rinolytic regulation occurs. Once the strong fibrinolysis 
begins; a large amount of fibrinogen may need to be supplied 
until newly formed cross-linked fibrin is tightened and subse-
quent clot formation is completed. Platelet function of 
patients with polycythemia may play another important role 
in this problem. In our preliminary data of the patients, very 
weak aggregation and poor a-granule release response have 
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been observed. We hypothesize that both strong fibrinolytic 
response and weakened platelet function could be the physio-
logic adaptation phenomenon against the great thrombotic 
risk. Intravenous fibrinogen administration is effective and the 
combination of fibrinogen and antifibrinolytic therapy may be 
the best conservative management available for serous leak-
age through PTFE so far. Further investigations are needed to 
prove our hypothesis. 
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Aortic function in patients during intra-aortic balloon 
pumping determined by the pressure-diameter 
relation 
To the Editor: 
Stefanadis and associates 1 provide an important analysis of 
aortic function in patients during intra-aortic balloon pump-
ing, which aids in the understanding of the improved circula-
tory function that results from its use. However, two points 
need further clarification. 
First, in Fig 4 they state that the fourth derivative of the aor-
tic pressure and diameter was used to estimate (1) minimum 
aortic pressure and diameter and (2) the point of inflection of 
the aortic pressure and diameter, thus allowing calculation of 
the pressure augmentation index. The fourth derivative has 
been previously described as the optimum way of deriving 
these points.2 
The use of the fourth derivative is against the basic princi-
ples of calculus, in which the first derivative is used to eval-
uate minima and maxima, with the second derivative used to 
distinguish between these and points of inflexion, negative at 
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Fig 1. Typical blood pressure tracing from a patient's aorta, and the first four derivatives (see text for explanation). 
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Fig 2. The effect of systemic vascular resistance on the aug-
mented pressure produced by an intra-aortic balloon pump. 
maxima; positive at minima, and zero at points of inflexion.3 
The thiIp and fourth derivatives have no use with regard to 
the aforementioned points. To prove this, we digitized the 
aortic blood pressure of a patient every 10 ms; the first four 
derivatives are shown in Fig 1. The first derivative crosses 
zero three times, indicating the maxima and two minima of 
the blo~d pressure trace. The second derivative is positive at 
the first and third zero point of the first derivative, indicating 
a minima, and is negative at the second zero point (it should 
be noted that the sign of the second derivative determines the 
maxima/minima status, and not the actual value). In addition, 
the second derivative is zero during the upstroke of the pres-
sure tracing, indicating that the point of inflection occurs at 
this point. 
Second, no measurements of systemic vascular resistance/ 
impedance (SVRlSVI) were made, and yet the SVR and SVI 
have a major effect on the pressure tracing that is obtained, 
thus influencing the augmentation index measured. Fig 2 
demonstrates the influence of SVR as measured by a ther-
modilution catheter (Swan-Ganz; Baxter Healthcare Corp, 
Edwards Div, Santa Ana, Calif) on the augment pressure 
generated by an intra-aortic balloon pump in 11 patients 
after cardiac surgery. It could be argued that the pressure 
augmentation index measured on the balloon pump augmen-
tation pulse would be more accurate than on the heart ejec-
tion pulse part of the blood pressure tracing, but this remains 
to be validated. 
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Reply to the Editor: 
Regarding the letter to the Editor referring to our article, 
"Aortic Function in Patients During Intra-aortic Balloon 
Pumping Detennined by the Pressure-Diameter Relation," 
we would like to state the following. 
First, wave reflections are evaluated by measuring aug-
mentation index, defined as the ratio: (pressure from inflec-
tion point to late systolic peak)/(pulse pressure).! Beginning 
of pressure wave upstroke, inflection point, and late systolic 
peak are defined by using the fourth derivative of pressure. 
When plotted against derivative, the timing of inflection 
point is indicated by a local minimum in the first derivative. 
To simplify the detection of this point, higher order deriva-
tives are used to identify the zero-crossing point equivalent 
to the local minimum of the first derivative. The first zero 
crossing of the fourth derivative (in a direction from above 
to below the zero line) corresponded to the beginning of the 
pressure wave upstroke. The second zero crossing in the 
same direction corresponded to the inflection point.! Scat-
ter in each primary pressure derivative is smoothed by 
applying moving average curve (Microsoft Excel 97 for 
Windows; Microsoft Corporation, Redmond, Wash). This 
resulted in phase shifts, which depend on the interval of the 
moving average. Phase shifts of all derivatives are adjusted 
accordingly. 
SecolJd, pressure augmentation index measured on the 
heart ejection part of the blood pressure tracing is the only 
way to appreciate, in a comparative manner, the changes of 
the reflected waves both at baseline and during intra-aortic 
balloon pumping.2 
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Myocardial pseudovascular tubes are present in the 
delayed rejection of pig-to-baboon orthotopic cardiac 
xenografts 
To the Editor: 
In the article by Xu and associates! dealing with the rejection 
of pig-to-baboon orthotopic cardiac xenografts, the authors 
describe microvascular thromboses in a heart that has survived 
19 days after transplantation (see their Fig 4). The individual 
thromboses are surrounded by damaged cardiomyocytes man-
ifesting a more or less shrunken nucleus located in the midst of 
a large myocytolytic vacuole or rarefied myofibrils. 
Having been intrigued by the curious shapes, high number, 
and large diameters of the alleged microthromboses, I have 
found that they often contain parts of cardiomyocytes in their 
lumina. Using Cartesian coordinates and centimeters as units 
for their exact localization in Fig 4, the microthrombosis-like 
structures containing cardiomyocyte nuclei are located at the 
following points: x = 0.6, y = 4.1; x = 1.7, y = 1.8; x = 2.5, y 
= 2.5; x = 6.9, y = 5.6; x = 7.3, Y = 3.3. The structures con-
taining myocytolytic vacuoles with or without nuclear 
remains are located at these points: x = 2.4, Y = 2.3; x = 3.8, 
y = 0.3; x = 5.8, y = 0.3; x = 6, y = 2.9; x = 6.8, y = 5.3; x = 
7.5, y = 3; x = 7.8, Y = 2.6. Finally, the large thrombus-like 
structure containing rarefied myofibrils is present at x = 7.7, 
Y = 3.8. Consequently, the alleged microthromboses are not 
vascular structures but "myocardial pseudovascular tubes"2 
formed by individual hyalinized cardiomyocytes or their bundles. 
Hyalinized cardiomyocytes may undergo apoptotic disinte-
gration into "eosinophilic droplets" similar to red cells,3,4 
creating an impression of interstitial hemorrhage. In Fig 4,! 
such a process is present in the form of a hook delineated by 
the points x = 3.5, y = 0; x = 3, y = 6; x = 7.5, Y = 6.9. Note 
the presence of several "naked" cardiomyocyte nuclei close 
to the point x = 6.5, y = 6.7. Free cardiomyocyte nuclei were 
described in Syrian hamster cardiomyopathy5 and in the 
delayed rejection of heart xenografts.4 Apparently, the apop-
totic disintegration of cytoplasm may precede that of the 
nucleus.6 
The purpose of this letter is not to deny the presence of 
genuine microthromboses, which were well documented by 
electron microscopy in the hyperacute and delayed rejections 
of cardiac xenografts and allografts,? but to increase the 
awareness of myocardial pseudovascular tubes in the same 
situations. 
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